In Vivo Evaluation of Candidate Allele-specific Mutant Huntingtin Gene Silencing Antisense OligonucleotidesAmber L. Southwell, Michael R. Hayden, Crystal N. Doty et al.|Molecular Therapy|2014Cited by 148
Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease PatientsNiels H. Skotte, Michael R. Hayden, Andrew T. Watt et al.|PLoS ONE|2014Cited by 114
A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin allelesAmber L. Southwell, Michael R. Hayden, Chris Kay et al.|Human Molecular Genetics|2017Cited by 36